Activities of Antiplasmin and Antiplasminogen Activator in Serous Middle Ear Effusions

Abstract

Antiplasmin and antiplasminogen activator activities in serous middle ear effusion (MEE) collected from adult patients were measured to analyze the kinetics of antifibrinolytic activity of protease inhibitors. No trypsin, plasmin, and plasminogen activator (PA) activity could be detected in the pooled serous MEE by either the fibrin plate method or the fluorometric assay. Antiplasmin activity in serous MEE was lower than that in plasma. The MEE had no antiurokinase activity. These findings indicate that 1) serous MEE has residual antifibrinolytic activity which may be attributed to mainly antiplasmin activity of unsaturated plasmin inhibitors and not to anti-PA activity, and 2) that serous MEE contains no secretory urokinase inhibitors.

Keywords

antiplasmin antiplasminogen activator serous middle ear effusions

Get full access to this article

View all access options for this article.

References

Carlsson

Lundberg

Ohlsson

. Protease inhibitors in middle ear effusions. Ann Otol Rhinol Laryngol 1981; 90: 38–41.

Hamaguchi

Sakakura

Ukai

Ohi

Miyoshi

. Antifibrinolytic activity in middle ear effusion. ORL 1984; 46: 235–41.

Lupovich

Harkins

. Symposium on prophylaxis and treatment of middle ear effusions. III. The pathophysiology of effusion in otitis media. Laryngoscope 1972; 82: 1647–53.

Carlsson

Lundberg

Ohlsson

. Granulocyte proteases in middle ear effusions. Ann Otol Rhinol Laryngol 1982; 91: 76–81.

Naumann

. On the defense mechanism of the respiratory mucosa towards infection. Acta Otolaryngol (Stockh) 1980; 89: 165–76.

Astrup

Mullertz

. The fibrin plate method for estimating fibrinolytic activity. Arch Biochem 1952; 40: 346–51.

Barrett

. Fluorometric assay for cathepsin B and cathepsin H with methylcoumarylamide substrates. J Biochem 1980; 187: 909–12.

Kanaoka

Takahashi

Nakayama

Takada

Kimura

Sakakibara

. Synthesis of a key fluorogenic amide, L-arginine-4-methylcoumaryl-7-amide (L-Arg-MCA) and its derivatives. Fluorescence assays for trypsin and papain. Chem Pharm Bull 1977; 25: 3126–8.

Kato

Adachi

Ohno

. New fluorogenic peptide substrates for plasmin. J Biochem 1980; 88: 183–90.

10.

Deutsch

Mertz

. Plasminogen purification from human plasma by affinity chromatography. Science 1970; 170: 1095–6.

11.

Ouchterlony

. Handbook of immunodiffusion and immunoelectrophoresis. Ann Arbor: Ann Arbor Science, 1968.

12.

Morita

Kato

Iwanaga

. New fluorogenic substrates for α-thrombin, factor Xa, kallikrein and urokinase. J Biochem 1977; 82: 1495–8.

13.

Laemmli

. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. J Mol Biol 1973; 80: 57–99.

14.

Bernstein

Villari

. The significance of lysosomal enzymes in middle ear effusions. Otolaryngol Head Neck Surg 1979; 87: 845–51.

15.

Moroi

Aoki

. Isolation and characterization of α₂-plasmin inhibitor from human plasma. J Biol Chem 1976; 19: 5956–65.

16.

Uszynski

. Isolation of peptides with anti-urokinase activity from human placenta. Thromb Haemost 1979; 42: 1411–6.